Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Cynapsus Therapeutics Inc.

Cynapsus Therapeutics Inc. (TSX: CTH, OTCQX: CYNAF) is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson’s disease. Based in Toronto, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010.

Investment goal date:
Dividends reinvested
Cynapsus Therapeutics Inc. CYNA report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks